Jefferies Raises Price Target on Chemours (CC) to $17; Reiterates Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Notable 52-Week Highs and Lows 11/7: (CC) (SNI) (VSH) High; (CXRX) (CEMP) (PLUG) Low
November 7, 2016 3:13 PM EST52-Week High:Chemours (NYSE: CC) $19.60. Chemours reported Q3 EPS of $0.61, versus the analyst estimate of $0.33. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
Scripps Networks Interactive, Inc. (Nasdaq: SNI) $68.49. Scripps Networks reported Q3... More
Pre-Open Stock Movers 11/07: (NILE) (N) (CEMP) (IONS) Higher; (CXRX) (PLUG) (LB) Lower (more...)
November 7, 2016 9:20 AM ESTPre-Open Stock Movers
Blue Nile (Nasdaq: NILE) 32.4% HIGHER; announced that it has entered into a definitive agreement to be acquired by an Investor Group comprised of funds managed by Bain Capital Private Equity and Bow Street LLC (collectively the Investor Group). The terms of the all-cash deal provide substantial value to Blue Niles stockholders. The Investor Group will acquire 100 percent of the outstanding shares of Blue Nile common stock for approximately $500 million. Blue Nile stockholders will receive $40.75 in cash per share, representing a premium of approximately 34 percent over Blue Niles closing price... More
Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%
November 7, 2016 7:51 AM ESTChemours (NYSE: CC) reported Q3 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
Highlights:
Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalizationImproved cash from operating activities by ~$440 million year-to-dateRetired $315 million of long term debt through October 31, 2016Generated ~$685 million in gross proceeds from Chemical Solutions divestituresIncreased full-year Adjusted EBITDA... More